Evidence map›Paper›PMID 38482263›Full record

ArticleBalkan journal of medical genetics : BJMG2023

Co-Existence of

K A Nestorovska, Z Naumovska, M Staninova Stojovska, Z Sterjev, A Dimovski, Lj Suturkova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Prevalence ofAnnals of neurosciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K A NestorovskaFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
Z NaumovskaFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
M Staninova StojovskaFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
Z SterjevFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
A DimovskiFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
Lj SuturkovaFaculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, RN Macedonia.
Ss. Cyril and Methodius University in Skopje · MK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD). Clopidogrel response is highly variable, mainly due to the presence of polymorphisms in the genes involved in drug metabolism. The aim of this study was to evaluate the association between the presence of the

Indexed as

ABCB1clopidogrelcoronary artery diseaseCYP2C19P-glycoproteinpharmacogenetics

Identifiers

PMID38482263
PMCPMC10932604
OpenAlexW4392683487

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.